---
version: 1
interactions:
- request:
    body: ""
    form: {}
    headers:
      User-Agent:
      - Mozilla/5.0 (Linux; Android 9; moto g(6)) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/76.0.3809.111 Mobile Safari/537.36
    url: https://finviz.com/quote.ashx?t=AEZS&ty=c&p=d&b=1
    method: GET
  response:
    body: "<!DOCTYPE HTML PUBLIC \"-//W3C//DTD HTML 4.0 Transitional//EN\">\n<html>\n<head>\n<title>AEZS Aeterna Zentaris Inc. Stock Quote</title>\n<meta name=\"description\" content=\"Stock screener for investors and traders, financial visualizations.\">\n<meta name=\"keywords\" content=\"Stock Screener, Charts, Quotes, Maps, News, Financial Visualizations, Research, Trading Systems\">\n<meta http-equiv=\"imagetoolbar\" content=\"no\">\n<meta http-equiv=\"pragma\" content=\"no-cache\">\n<meta http-equiv=\"cache-control\" content=\"no-cache\">\n<meta http-equiv=\"Expires\" content=\"-1\">\n<link href=\"//fonts.googleapis.com/css?family=Lato:400,700,900\" rel=\"stylesheet\" type=\"text/css\"><link rel=\"stylesheet\" href=\"/css/finviz_old.css?rev=151\" type=\"text/css\">\n<link rel=\"icon\" type=\"image/png\" href=\"/favicon_2x.png\" sizes=\"32x32\">\n<link rel=\"icon\" type=\"image/png\" href=\"/favicon.png\" sizes=\"16x16\">\n<script src=\"/script/boxover.js?rev=249\" type=\"text/javascript\"></script>\n<script type=\"text/javascript\">FinvizSettings = {hasUserPremium: false, name: \"\", chartsDomain: \"https://charts2.finviz.com\"};</script><script type=\"text/javascript\" src=\"/js/libs/shims.min.js?rev=249\"></script><script type=\"text/javascript\" src=\"/js/libs/d3-json.js?rev=249\"></script>\r\n            <script type=\"text/javascript\" src=\"/js/dist/runtime.bundle.js?rev=249\"></script>\r\n            <script type=\"text/javascript\" src=\"/js/dist/vendors.bundle.js?rev=249\"></script>\r\n            <script type=\"text/javascript\" src=\"/js/dist/header.bundle.js?rev=249\"></script>\r\n        <script src=\"/script/ajax.js\" type=\"text/javascript\"></script>\n<script src=\"/script/quote.js?rev=249\" type=\"text/javascript\"></script>\n<script src=\"/script/ta_settings.js?rev=249\" type=\"text/javascript\"></script>\n\r\n            <script src=\"/js/dfp.min.js\"></script>\r\n            <script>\r\n                if(window['FinvizLoadIC']) {\r\n                    var s = document.createElement('script');\r\n                    s.type = 'text/javascript';\r\n                    s.async = true;\r\n                    s.src = 'https://u5.investingchannel.com/static/uat.js';\r\n                    document.head.appendChild(s);\r\n\r\n                    InvestingChannelQueue = window.InvestingChannelQueue || [];\r\n                    var ic_page;\r\n                    InvestingChannelQueue.push(function() {\r\n                        ic_page = InvestingChannel.UAT.Run('df0d0d52-cc7f-11e8-82a5-0abbb61c4a6a');\r\n                    });\r\n                } else {\r\n            (function() {\r\n                function ready(fn) {if (document.readyState != 'loading'){fn();}else{document.addEventListener('DOMContentLoaded', fn);} }\r\n                ready(function() {\r\n                    var banners = ['2', '4', '5', '6', '7'];\r\n                    var banner = banners[Math.floor(Math.random() * banners.length)];\r\n\r\n                    if (banner === '3') {\r\n                        document.getElementById('banner_position').innerHTML = '<iframe src=\"/img/a/' + banner + '/index.html?rev=2\" frameBorder=\"0\" width=\"728\" height=\"90\"></iframe>';\r\n                    } else {\r\n                        document.getElementById('banner_position').innerHTML = '<a href=\"/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=' + banner + '\"><img src=\"/img/a/' + banner + '.jpg\"></a>';\r\n                    }\r\n                    gtag && gtag('event', 'impression', { event_category: 'banner', event_label: banner, non_interaction: true });\r\n                })\r\n            })();\r\n        \r\n                }\r\n            </script></head>\n<body onload=\"(typeof StocktwitsInit === 'function' && StocktwitsInit());(SetSearchExt && SetSearchExt('&ty=c&ta=1&p=d'));\" style=\"margin:0\" bgcolor=\"#ffffff\">\n<div id=\"unsupported-browser\">Your browser is no longer supported. Please, <a href=\"https://browser-update.org/update.html\" target=\"_blank\">upgrade your browser.</a></div>\r\n                <table class=\"header\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\" style=\"min-width: 1000px\">\r\n                    <tr valign=\"top\">\r\n                        <td>\r\n                            <script type=\"text/javascript\">if(document.body.clientWidth>1500){document.write('<table align=\"center\" width=\"1425px\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\" style=\"table-layout: fixed; min-width: 1000px\">')}else{document.write('<table align=\"center\" width=\"95%\" style=\"max-width: 1425px; min-width: 1000px; table-layout: fixed\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">')}</script>\r\n                                <tr>\r\n                                    <td width=\"30%\">\r\n                                        <table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\r\n                                            <tr>\r\n                                                <td height=\"50\" valign=\"middle\">\r\n                                                    <a href=\"/\" class=\"logo\"></a>\r\n                                                </td>\r\n                                            </tr>\r\n                                            <tr>\r\n                                                <td class=\"search\" id=\"search\" style=\"padding-top: 4px\">\r\n                                                    <form style=\"margin: 0\">\r\n                                                        <input placeholder=\"Search ticker, company or profile\" type=\"text\" value=\"\">\r\n                                                        <span class=\"fa fa-search\"></span>\r\n                                                    </form>\r\n                                                </td>\r\n                                            </tr>\r\n                                        </table>\r\n                                    </td>\r\n                                    <td valign=\"bottom\" style=\"padding-bottom: 4px\">\r\n                                        <div id=\"microbar_position\" style=\"height: 31px\"></div>\r\n                                    </td>\r\n                                    <td width=\"728\" align=\"right\" style=\"position:relative;\"><div id=\"banner_position\" style=\"position:absolute;right:0;top:0;overflow:hidden;height:96px\"></div></td>\r\n                                </tr>\r\n                            </table>\r\n                        </td>\r\n                    </tr>\r\n                    <tr>\r\n                        <td width=\"1000\" style=\"font-size:0\">\r\n                            <img src=\"/gfx/nic2x2.gif\" width=\"1000\" height=\"1\" border=\"0\">\r\n                        </td>\r\n                    </tr>\r\n                </table>\r\n            <table class=\"navbar\" width=\"100%\" height=\"30\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\r\n                <tr>\r\n                    <td height=\"30\">\r\n                        <script type=\"text/javascript\">if(document.body.clientWidth>1500){document.write('<table align=\"center\" width=\"1425px\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\" style=\"white-space: nowrap; min-width: 1000px\">')}else{document.write('<table align=\"center\" width=\"95%\" style=\"max-width:1425px;white-space: nowrap;min-width: 1000px\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">')}</script>\r\n                            <tr height=\"30\"><td><a class=\"nav-link  is-first\" href=\"/\">Home</a></td><td><a class=\"nav-link \" href=\"/news.ashx\">News</a></td><td><a class=\"nav-link \" href=\"/screener.ashx\">Screener</a></td><td><a class=\"nav-link \" href=\"/map.ashx\">Maps</a></td><td><a class=\"nav-link \" href=\"/groups.ashx\">Groups</a></td><td><a class=\"nav-link \" href=\"/portfolio.ashx\">Portfolio</a></td><td><a class=\"nav-link \" href=\"/insidertrading.ashx\">Insider</a></td><td><a class=\"nav-link \" href=\"/futures.ashx\">Futures</a></td><td><a class=\"nav-link \" href=\"/forex.ashx\">Forex</a></td><td><a class=\"nav-link \" href=\"/crypto.ashx\">Crypto</a></td><td><a class=\"nav-link \" href=\"/backtests.ashx\">Backtests</a></td><td><a class=\"nav-link  is-elite\" href=\"/elite.ashx\">Elite</a></td><td style=\"width: 100%\"></td>\r\n                                <td class=\"time\" id=\"time\"></td>\r\n                <td>\r\n                    <a href=\"/help/screener.ashx\" class=\"nav-link is-help\">\r\n                        <span class=\"fa fa-question-circle\"></span>\r\n                        Help\r\n                    </a>\r\n                </td>\r\n                <td><a href=\"/login.ashx\" class=\"nav-link sign-in\">Login</a></td>\r\n                <td><a href=\"/register.ashx\" class=\"nav-link sign-up\">Register</a></td>\r\n            \r\n                            </tr>\r\n                        </table>\r\n                    </td>\r\n                </tr>\r\n            </table>\r\n        <script type=\"text/javascript\">if(document.body.clientWidth>1500){document.write('<table align=\"center\" width=\"1425px\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">')}else{document.write('<table align=\"center\" width=\"95%\" style=\"max-width:1425px;\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">')}</script>\n<tr>\n<td>\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr><td><img src=\"/gfx/nic2x2.gif\" width=\"2\" height=\"7\" alt=\"\" border=\"0\"></td></tr>\n<tr><td width=\"100%\"><img src=\"/gfx/nic2x2.gif\" width=\"2\" height=\"15\" alt=\"\" border=\"0\"></td></tr>\n<tr>\r\n                <td width=\"100%\">\r\n                    <div id=\"quote-ad\" style=\"background: #fffce5; border: 1px solid #fee500; color: #363a46; display: none; font-family: Lato; font-size: 13px; line-height: 36px; text-align: center; width: 945px; margin: -10px auto 10px auto;position: relative;\">\r\n                        <b>TIP: </b>\r\n                        <a href=\"/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=quote\" target=\"blank\" onclick=\"gtag('event', 'click', { event_category: 'bannerQuote' });\" style=\"color: #1E6DC0;\">Upgrade to FINVIZ*Elite</a> to get real-time quotes, intraday charts, and advanced charting tools.\r\n                        <a title=\"Close\" class=\"close\" onclick=\"Finviz.quoteAd.close();\" href=\"javascript:void(0)\" style=\"\r\n                            position: absolute;\r\n                            margin-right: 0;\r\n                            right: 10px;\r\n                            color: #363a46;\r\n                            text-decoration: none;\r\n\t                    \">Ã—</a>\r\n                    </div>\r\n                    <script src=\"/js/quote_a.js?rev=2\" async></script>\r\n                </td>\r\n            </tr>\r\n        <tr valign=\"bottom\"><td align=\"center\">\n<table  cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr>\n<td class=\"fullview-links\" align=\"left\" valign=\"center\">\n<a href=\"javascript:Publish('t=AEZS&ty=c&ta=1&p=d&s=l')\" class=\"tab-link\">publish chart</a> | <a href=\"/save_to_portfolio.ashx?t=AEZS\" class=\"tab-link\">save to portfolio</a> | <a href=\"/create_alert.ashx?t=AEZS\" class=\"tab-link\">create alert</a>&nbsp;<img src=\"/gfx/nic2x2.gif\" width=\"20\" height=\"14\" border=\"0\" alt=\"\"><span class=\"count-text\"><b>Type:</b></span> <a href=\"quote.ashx?t=AEZS&ty=c&ta=0&p=d&b=1\" class=\"tab-link\">candle</a> | <a href=\"quote.ashx?t=AEZS&ty=l&ta=0&p=d&b=1\" class=\"tab-link\">line</a> | <a href=\"quote.ashx?t=AEZS&ty=c&ta=1&p=d&b=1\" class=\"tab-link\"><b>advanced</b></a> | <a href=\"/elite.ashx\" class=\"tab-link\">interactive</a> | <a href=\"/elite.ashx\" class=\"tab-link\">perf</a>&nbsp;&nbsp;&nbsp;&nbsp;<span class=\"count-text\"><b>Timeframe:</b></span> <a href=\"elite.ashx\" class=\"tab-link\">intraday</a> | </span><a href=\"quote.ashx?t=AEZS&ty=c&ta=1&p=d&b=1\" class=\"tab-link\"><b>daily</b></a> | <a href=\"quote.ashx?t=AEZS&ty=c&ta=0&p=w&b=1\" class=\"tab-link\">weekly</a> | <a href=\"quote.ashx?t=AEZS&ty=c&ta=0&p=m&b=1\" class=\"tab-link\">monthly</a>&nbsp;&nbsp;</td><td align=\"left\" valign=\"top\" class=\"ta-settings-button\" style=\"position: relative\"><a href=\"elite.ashx\" class=\"ta-settings-button\">Settings<img src=\"gfx/ta_settings_arrow_d.gif\" width=\"21\" height=\"9\" alt=\"\" border=\"0\"></a></td>\n</tr>\n</table>\n</td>\n</tr>\n<tr><td width=\"100%\"><img src=\"gfx/nic2x2.gif\" width=\"2\" height=\"16\" alt=\"\" border=\"0\"></td></tr>\n<tr>\n<td>\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr>\n<td align=\"center\" valign=\"top\">\n<img id=\"chart0\" src=\"https://charts2.finviz.com/chart.ashx?t=AEZS&ty=c&ta=1&p=d&s=l\" alt=\"AEZS Aeterna Zentaris Inc. daily Stock Chart\" height=\"340\" border=\"0\"/>\n</td>\n</tr>\n<tr>\n<td align=\"center\" valign=\"top\">\n<table width=\"100%\" cellpadding=\"3\" cellspacing=\"0\" bgcolor=\"#ffffff\" class=\"fullview-title\">\n<tr><td align=\"center\"><a href=\"quote.ashx?t=AEZS&ty=c&ta=1&p=d&b=1\" class=\"fullview-ticker\" id=\"ticker\">AEZS</a> <span class=\"body-table\">[NASD]</span></td></tr>\n<tr><td align=\"center\"><a href=\"http://www.zentaris.com\" target=\"_blank\" class=\"tab-link\"><b>Aeterna Zentaris Inc.</b></a></td></tr>\n<tr><td align=\"center\" class=\"fullview-links\"><a href=\"screener.ashx?v=111&f=sec_healthcare\" class=\"tab-link\">Healthcare</a> | <a href=\"screener.ashx?v=111&f=ind_biotechnology\" class=\"tab-link\">Biotechnology</a> | <a href=\"screener.ashx?v=111&f=geo_usa\" class=\"tab-link\">USA</a></td></tr>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table width=\"100%\" cellpding=\"0\" cellspacing=\"0\" class=\"fullview-links\">\n<td align=\"left\" width=\"80%\">\n</td>\n<td align=\"right\" width=\"20%\">\n<a class=\"tab-link\" href=\"#statements\">statements</a></td>\n</tr>\n</table>\n</tr>\n</td>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table width=\"100%\" cellpadding=\"3\" cellspacing=\"0\" border=\"0\" class=\"snapshot-table2\">\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Major index membership] offsetx=[10] offsety=[20] delay=[300]\">Index</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings (ttm)] offsetx=[10] offsety=[20] delay=[300]\">P/E</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Diluted EPS (ttm)] offsetx=[10] offsety=[20] delay=[300]\">EPS (ttm)</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-0.18</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider ownership] offsetx=[10] offsety=[20] delay=[300]\">Insider Own</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.60%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares outstanding] offsetx=[10] offsety=[20] delay=[300]\">Shs Outstand</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>62.68M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Week)] offsetx=[10] offsety=[20] delay=[300]\">Perf Week</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">20.00%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Market capitalization] offsetx=[10] offsety=[20] delay=[300]\">Market Cap</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>21.30M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Forward Price-to-Earnings (next fiscal year)] offsetx=[10] offsety=[20] delay=[300]\">Forward P/E</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next year] offsetx=[10] offsety=[20] delay=[300]\">EPS next Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Insider transactions (6-Month change in Insider Ownership)] offsetx=[10] offsety=[20] delay=[300]\">Insider Trans</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.00%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Shares float] offsetx=[10] offsety=[20] delay=[300]\">Shs Float</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>62.63M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Month)] offsetx=[10] offsety=[20] delay=[300]\">Perf Month</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">17.61%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Income (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Income</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-4.80M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Earnings-to-Growth] offsetx=[10] offsety=[20] delay=[300]\">PEG</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS estimate for next quarter] offsetx=[10] offsety=[20] delay=[300]\">EPS next Q</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional ownership] offsetx=[10] offsety=[20] delay=[300]\">Inst Own</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>21.40%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest share] offsetx=[10] offsety=[20] delay=[300]\">Short Float</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>1.54%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Quarter)] offsetx=[10] offsety=[20] delay=[300]\">Perf Quarter</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-14.81%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Revenue (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Sales</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>1.30M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Sales (ttm)] offsetx=[10] offsety=[20] delay=[300]\">P/S</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">16.38</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth this year] offsetx=[10] offsety=[20] delay=[300]\">EPS this Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-240.50%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Institutional transactions (3-Month change in Institutional Ownership)] offsetx=[10] offsety=[20] delay=[300]\">Inst Trans</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>2.07%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Short interest ratio] offsetx=[10] offsety=[20] delay=[300]\">Short Ratio</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.41</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Half Year)] offsetx=[10] offsety=[20] delay=[300]\">Perf Half Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-63.48%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Book value per share (mrq)] offsetx=[10] offsety=[20] delay=[300]\">Book/sh</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.27</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price-to-Book (mrq)] offsetx=[10] offsety=[20] delay=[300]\">P/B</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>1.56</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[EPS growth next year] offsetx=[10] offsety=[20] delay=[300]\">EPS next Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Assets (ttm)] offsetx=[10] offsety=[20] delay=[300]\">ROA</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-21.50%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean target price] offsetx=[10] offsety=[20] delay=[300]\">Target Price</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year)] offsetx=[10] offsety=[20] delay=[300]\">Perf Year</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-53.28%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]\">Cash/sh</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.43</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to cash per share (mrq)] offsetx=[10] offsety=[20] delay=[300]\">P/C</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">0.98</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long term annual growth estimate (5 years)] offsetx=[10] offsety=[20] delay=[300]\">EPS next 5Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Equity (ttm)] offsetx=[10] offsety=[20] delay=[300]\">ROE</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-125.80%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[52-Week trading range] offsetx=[10] offsety=[20] delay=[300]\">52W Range</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><small>0.29 - 1.54</small></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (Year To Date)] offsetx=[10] offsety=[20] delay=[300]\">Perf YTD</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-53.85%</span></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend (annual)] offsetx=[10] offsety=[20] delay=[300]\">Dividend</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Price to Free Cash Flow (ttm)] offsetx=[10] offsety=[20] delay=[300]\">P/FCF</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual EPS growth past 5 years] offsetx=[10] offsety=[20] delay=[300]\">EPS past 5Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">58.80%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Return on Investment (ttm)] offsetx=[10] offsety=[20] delay=[300]\">ROI</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">628.40%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week High] offsetx=[10] offsety=[20] delay=[300]\">52W High</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-74.06%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Beta] offsetx=[10] offsety=[20] delay=[300]\">Beta</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>2.08</b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend yield (annual)] offsetx=[10] offsety=[20] delay=[300]\">Dividend %</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quick Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]\">Quick Ratio</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">12.80</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Annual sales growth past 5 years] offsetx=[10] offsety=[20] delay=[300]\">Sales past 5Y</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">117.20%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Gross Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Gross Margin</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>6.70%</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 52-Week Low] offsetx=[10] offsety=[20] delay=[300]\">52W Low</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">37.77%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average True Range (14)] offsetx=[10] offsety=[20] delay=[300]\">ATR</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.03</b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Full time employees] offsetx=[10] offsety=[20] delay=[300]\">Employees</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>11</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current Ratio (mrq)] offsetx=[10] offsety=[20] delay=[300]\">Current Ratio</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">13.00</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly revenue growth (yoy)] offsetx=[10] offsety=[20] delay=[300]\">Sales Q/Q</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-66.70%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Operating Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Oper. Margin</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative Strength Index] offsetx=[10] offsety=[20] delay=[300]\">RSI (14)</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>62.94</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volatility (Week, Month)] offsetx=[10] offsety=[20] delay=[300]\">Volatility</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><small>13.92% 9.04%</small></b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Stock has options trading on a market exchange] offsetx=[10] offsety=[20] delay=[300]\">Optionable</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>Yes</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Total Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]\">Debt/Eq</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">0.01</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Quarterly earnings growth (yoy)] offsetx=[10] offsety=[20] delay=[300]\">EPS Q/Q</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-3.10%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Net Profit Margin (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Profit Margin</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Relative volume] offsetx=[10] offsety=[20] delay=[300]\">Rel Volume</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>1.00</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Previous close] offsetx=[10] offsety=[20] delay=[300]\">Prev Close</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.42</b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Stock available to sell short] offsetx=[10] offsety=[20] delay=[300]\">Shortable</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>Yes</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Long Term Debt to Equity (mrq)] offsetx=[10] offsety=[20] delay=[300]\">LT Debt/Eq</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">0.01</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Earnings date<br><br>BMO = Before Market Open<br>AMC = After Market Close] offsetx=[10] offsety=[20] delay=[300]\">Earnings</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Dividend Payout Ratio (ttm)] offsetx=[10] offsety=[20] delay=[300]\">Payout</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Average volume (3 month)] offsetx=[10] offsety=[20] delay=[300]\">Avg Volume</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>2.34M</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Current stock price] offsetx=[10] offsety=[20] delay=[300]\">Price</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>0.40</b></td>\n</tr>\n<tr class=\"table-dark-row\">\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Analysts' mean recommendation (1=Buy 5=Sell)] offsetx=[10] offsety=[20] delay=[300]\">Recom</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>-</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 20-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]\">SMA20</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">19.03%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 50-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]\">SMA50</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-green\">13.16%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Distance from 200-Day Simple Moving Average] offsetx=[10] offsety=[20] delay=[300]\">SMA200</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-36.58%</span></b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Volume] offsetx=[10] offsety=[20] delay=[300]\">Volume</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b>1,568,108</b></td>\n<td width=\"7%\" class=\"snapshot-td2-cp\" align=\"left\" title=\"cssbody=[tooltip_short_bdy] cssheader=[tooltip_short_hdr] body=[Performance (today)] offsetx=[10] offsety=[20] delay=[300]\">Change</td><td width=\"8%\" class=\"snapshot-td2\" align=\"left\"><b><span class=\"is-red\">-4.88%</span></b></td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr><td align=\"center\"></td></tr><tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr>\n<td>\n<table width=\"100%\" class=\"fullview-ratings-outer\" cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Jul-19-17</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Maxim Group</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$2 &rarr; $4</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">May-10-17</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$7.50 &rarr; $3</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">May-01-17</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Maxim Group</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$11 &rarr; $2</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Jan-17-17</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Maxim Group</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$7 &rarr; $10</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Dec-02-15</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$11 &rarr; $12</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Nov-24-15</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$0.11 &rarr; $11</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Nov-23-15</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Maxim Group</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$200 &rarr; $11</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-upgrade\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-upgrade\"><td width=\"120\" align=\"left\">Apr-14-15</td><td width=\"200\" align=\"left\"><b>Upgrade</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Neutral &rarr; Buy</td>\n<td width=\"150\" align=\"left\">$1.25</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-downgrade\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-downgrade\"><td width=\"120\" align=\"left\">Nov-06-14</td><td width=\"200\" align=\"left\"><b>Downgrade</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Buy &rarr; Neutral</td>\n<td width=\"150\" align=\"left\"></td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Jul-17-14</td><td width=\"200\" align=\"left\"><b>Initiated</b></td>\n<td width=\"250\" align=\"left\">H.C. Wainwright</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$3</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-upgrade\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-upgrade\"><td width=\"120\" align=\"left\">Jan-03-13</td><td width=\"200\" align=\"left\"><b>Upgrade</b></td>\n<td width=\"250\" align=\"left\">MLV &amp; Co</td>\n<td width=\"250\" align=\"left\">Hold &rarr; Buy</td>\n<td width=\"150\" align=\"left\">$5.50</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Oct-09-12</td><td width=\"200\" align=\"left\"><b>Initiated</b></td>\n<td width=\"250\" align=\"left\">Maxim Group</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$9</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-downgrade\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-downgrade\"><td width=\"120\" align=\"left\">Apr-02-12</td><td width=\"200\" align=\"left\"><b>Downgrade</b></td>\n<td width=\"250\" align=\"left\">MLV &amp; Co</td>\n<td width=\"250\" align=\"left\">Buy &rarr; Hold</td>\n<td width=\"150\" align=\"left\"></td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Jun-07-11</td><td width=\"200\" align=\"left\"><b>Initiated</b></td>\n<td width=\"250\" align=\"left\">Oppenheimer</td>\n<td width=\"250\" align=\"left\">Outperform</td>\n<td width=\"150\" align=\"left\">$5.50</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Apr-27-11</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Canaccord Genuity</td>\n<td width=\"250\" align=\"left\">Speculative Buy</td>\n<td width=\"150\" align=\"left\">$2.75 &rarr; $4</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Nov-29-10</td><td width=\"200\" align=\"left\"><b>Initiated</b></td>\n<td width=\"250\" align=\"left\">MLV Capital</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$5.50</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-upgrade\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-upgrade\"><td width=\"120\" align=\"left\">Feb-05-09</td><td width=\"200\" align=\"left\"><b>Upgrade</b></td>\n<td width=\"250\" align=\"left\">RBC Capital Mkts</td>\n<td width=\"250\" align=\"left\">Sector Perform &rarr; Outperform</td>\n<td width=\"150\" align=\"left\"></td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Jun-03-08</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Canaccord Adams</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$3.20 &rarr; $2.65</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Apr-14-08</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Canaccord Adams</td>\n<td width=\"250\" align=\"left\">Buy</td>\n<td width=\"150\" align=\"left\">$4.50 &rarr; $3.20</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr class=\"body-table-rating-neutral\"><td class=\"fullview-ratings-inner\"><table cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr class=\"body-table-rating-neutral\"><td width=\"120\" align=\"left\">Oct-03-07</td><td width=\"200\" align=\"left\"><b>Reiterated</b></td>\n<td width=\"250\" align=\"left\">Rodman &amp; Renshaw</td>\n<td width=\"250\" align=\"left\">Mkt Outperform</td>\n<td width=\"150\" align=\"left\">$8 &rarr; $6</td>\n</tr>\n</table>\n</td>\n</tr>\n</table>\n</td>\n</tr>\n<tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr>\n<td>\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\"><tr><td><table width=\"100%\" cellpadding=\"1\" cellspacing=\"0\" border=\"0\" id=\"news-table\" class=\"fullview-news-outer\">\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-16-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-amends-license-agreement-130500364.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-06-20 08:35AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-third-quarter-133500106.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Oct-09-20 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/rosen-law-firm-p-glancy-120000154.html\" target=\"_blank\" class=\"tab-link-news\">The Rosen Law Firm, P.A. and Glancy Prongay &amp; Murray LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Aeterna Zentaris, Inc. - AEZS</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> PR Newswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-16-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-provides-corporate-120500072.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Provides Corporate Update</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-09-20 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-present-h-c-120000198.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris to Present at the H.C. Wainwright 22nd Annual Global Investment Conference</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">07:23AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/daily-biotech-pulse-astrazeneca-pauses-112314380.html\" target=\"_blank\" class=\"tab-link-news\">The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Benzinga</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-08-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announced-presentation-positive-120500528.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announced Presentation of Positive Results from First Pediatric Study of Macimorelin at the 22nd European Congress of Endocrinology</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-06-20 08:35AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-second-quarter-123500823.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-05-20 05:45PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-closing-7-214500597.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-03-20 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-7-0-130000971.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-8.63%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-31-20 07:35AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-continued-expansion-113500562.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-30-20 07:35AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-abstract-results-113500087.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-29-20 07:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-receives-nasdaq-notification-110500591.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-07-20 04:05PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-closing-12-200510610.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+24.53%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-03-20 07:12AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-tse-aezs-good-111213358.html\" target=\"_blank\" class=\"tab-link-news\">Is Aeterna Zentaris (TSE:AEZS) In A Good Position To Deliver On Growth Plans?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Simply Wall St.</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-01-20 10:10PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-pricing-12-021010150.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERING</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-32.67%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jun-25-20 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-distribution-agreement-120010436.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+5.58%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jun-08-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-regains-compliance-nasdaq-120510652.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jun-04-20 04:05PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-receives-extension-nasdaq-200510182.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-15-20 04:45PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-results-2020-204510653.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-08-20 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-virtual-2020-130010291.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-06-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-first-quarter-120510742.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+31.54%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-03-20 07:30PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/one-biotech-stock-2020-233000094.html\" target=\"_blank\" class=\"tab-link-news\">One Biotech Stock For 2020</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Oilprice.com</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-30-20 03:08PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/video/gileads-remdesivir-set-standard-care-190859138.html\" target=\"_blank\" class=\"tab-link-news\">Gilead's remdesivir will set new standard of care for coronavirus treatment: Fauci</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Yahoo Finance Video</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-15-20 04:06PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-receives-nasdaq-notice-200610791.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">09:15AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-present-april-2020-131510681.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-07-20 01:00PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-ema-decision-170010030.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES EMA DECISION TO ACCEPT A MODIFICATION TO AN AGREED PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-06-20 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-positive-results-130010923.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES POSITIVE RESULTS IN DOSE-FINDING PEDIATRIC STUDY OF MACIMORELIN</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+55.72%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-03-20 10:36AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/video/well-weather-coronavirus-storm-well-143643387.html\" target=\"_blank\" class=\"tab-link-news\">We'll weather the coronavirus storm well and come out very strong: Cigna Services President</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Yahoo Finance Video</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-30-20 05:00PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-fourth-quarter-210010302.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-8.51%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-12-20 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-settlement-previously-120010848.html\" target=\"_blank\" class=\"tab-link-news\">AETERNA ZENTARIS ANNOUNCES SETTLEMENT OF PREVIOUSLY DISCLOSED CLASS-ACTION LAWSUIT</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-17.74%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-21-20 02:00PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-closing-4-190010596.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Closing of $4.5 Million Registered Direct Offering Priced At-The-Market</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-20-20 07:06AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/daily-biotech-pulse-heron-pain-120625081.html\" target=\"_blank\" class=\"tab-link-news\">The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Benzinga</span> <span class=\"body-table-news-loss\">-25.00%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-19-20 07:00PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-4-5-000010958.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces $4.5 Million Registered Direct Offering Priced At-The-Market</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-12-20 08:05AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-present-noble-capital-130510177.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris to Present at Noble Capital Markets' 16th Annual Investor Conference</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-28-20 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-completion-patient-130010828.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Completion of Patient Recruitment in Dose-Finding Pediatric Study of Macimorelin</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-27-20 08:35AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-regains-compliance-nasdaq-133510364.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement for Continued Listing</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-09-20 08:39AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/daily-biotech-pulse-mercks-keytruda-133954562.html\" target=\"_blank\" class=\"tab-link-news\">The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Benzinga</span> <span class=\"body-table-news-loss\">-9.02%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-08-20 04:01PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-receives-nasdaq-notification-210110990.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+14.42%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-30-19 06:38AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/companies-aeterna-zentaris-tse-aezs-113826612.html\" target=\"_blank\" class=\"tab-link-news\">Companies Like Aeterna Zentaris (TSE:AEZS) Can Be Considered Quite Risky</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Simply Wall St.</span> <span class=\"body-table-news-gain\">+15.20%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-20-19 05:45PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/hedge-funds-never-bullish-aeterna-224552287.html\" target=\"_blank\" class=\"tab-link-news\">Hedge Funds Have Never Been This Bullish On AEterna Zentaris Inc. (AEZS)</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Insider Monkey</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-18-19 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-publication-ghd-140010572.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Publication of GHD Management Guidelines</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-16-19 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-2020-director-140010808.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces 2020 Director Changes</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-07-19 06:28PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-third-quarter-232855695.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Third Quarter 2019 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-05-19 07:56AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/top-ranked-value-stocks-buy-125612485.html\" target=\"_blank\" class=\"tab-link-news\">Top Ranked Value Stocks to Buy for November 5th</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-gain\">+7.46%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Oct-29-19 10:33AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/analysts-estimate-aeterna-zentaris-aezs-143302648.html\" target=\"_blank\" class=\"tab-link-news\">Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Oct-08-19 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/makes-aeterna-zentaris-aezs-buy-130001777.html\" target=\"_blank\" class=\"tab-link-news\">What Makes Aeterna Zentaris (AEZS) a New Buy Stock</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Oct-04-19 04:59PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-appointment-president-205936779.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Appointment of New President and Chief Executive Officer</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-26-19 06:34AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/see-significant-institutional-ownership-aeterna-103439893.html\" target=\"_blank\" class=\"tab-link-news\">Can We See Significant Institutional Ownership On The Aeterna Zentaris Inc. (TSE:AEZS) Share Register?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Simply Wall St.</span> <span class=\"body-table-news-loss\">-5.13%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-24-19 04:01PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-closing-approximately-200100575.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-20-19 11:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-pricing-approximately-150054091.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-22.42%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-20-19 11:16PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-director-change-031600959.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Director Change</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-13-19 05:45PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-beats-q2-214509423.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Beats Q2 Earnings Estimates</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-gain\">+11.16%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">04:15PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-second-quarter-201500866.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-01-19 10:33AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-report-negative-143302533.html\" target=\"_blank\" class=\"tab-link-news\">Will Aeterna Zentaris (AEZS) Report Negative Q2 Earnings? What You Should Know</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-loss\">-5.20%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jul-01-19 10:30AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/options-traders-expect-huge-moves-143002914.html\" target=\"_blank\" class=\"tab-link-news\">Options Traders Expect Huge Moves in Aeterna Zentaris (AEZS) Stock</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jun-06-19 02:06PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-provides-corporate-180640331.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Provides Corporate Update</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-13.38%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-08-19 06:04PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-results-annual-220422972.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-11.32%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-07-19 07:25PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-reports-q1-232511469.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Reports Q1 Loss, Misses Revenue Estimates</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">06:22PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-1q-earnings-snapshot-222218627.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris: 1Q Earnings Snapshot</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Associated Press</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">05:12PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-first-quarter-211212554.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">May-02-19 10:02AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/whats-cards-aeterna-aezs-earnings-140202637.html\" target=\"_blank\" class=\"tab-link-news\">What's in the Cards for AEterna (AEZS) This Earnings Season?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Apr-29-19 10:31AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/analysts-estimate-aeterna-zentaris-aezs-143102928.html\" target=\"_blank\" class=\"tab-link-news\">Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-26-19 07:50PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-4q-earnings-snapshot-235043015.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris: 4Q Earnings Snapshot</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Associated Press</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">05:22PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-fourth-quarter-212203989.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-19-19 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announce-fourth-quarter-120000695.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+5.50%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-18-19 11:18AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-moves-buy-151803113.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-13-19 07:27AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/daily-biotech-pulse-aeterna-zentaris-112736835.html\" target=\"_blank\" class=\"tab-link-news\">The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Benzinga</span> <span class=\"body-table-news-gain\">+8.40%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-12-19 04:32PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-strategic-review-203237740.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Mar-04-19 08:58AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/whats-cards-aeterna-aezs-earnings-135801397.html\" target=\"_blank\" class=\"tab-link-news\">What's in the Cards for Aeterna (AEZS) This Earnings Season?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-loss\">-5.50%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-27-19 09:57AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-145702984.html\" target=\"_blank\" class=\"tab-link-news\">The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-26-19 08:55AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/4-drug-stocks-buy-despite-135501317.html\" target=\"_blank\" class=\"tab-link-news\">4 Drug Stocks to Buy Despite Price Hearing Woes</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-14-19 10:45AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-biodelivery-154503389.html\" target=\"_blank\" class=\"tab-link-news\">The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Feb-13-19 08:36AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/5-tiny-biotech-stocks-superb-133601469.html\" target=\"_blank\" class=\"tab-link-news\">5 Tiny Biotech Stocks With Superb Growth Potential</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-29-19 09:30AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-outperforming-other-143002771.html\" target=\"_blank\" class=\"tab-link-news\">Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">08:48AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/implied-volatility-surging-aeterna-zentaris-134801328.html\" target=\"_blank\" class=\"tab-link-news\">Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-16-19 09:03AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-receives-european-marketing-140300200.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Receives European Marketing Clearance for Macimorelin</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-10.00%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-09-19 09:50AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/amgens-osteoporosis-candidate-evenity-gets-145002515.html\" target=\"_blank\" class=\"tab-link-news\">Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Jan-07-19 09:30AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-outperforming-other-143002061.html\" target=\"_blank\" class=\"tab-link-news\">Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-24-18 05:50PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-stock-moves-225010990.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Stock Moves -1.16%: What You Should Know</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-21-18 05:04PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-settles-dispute-david-220432233.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-loss\">-5.82%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-20-18 09:30AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-stock-outpacing-143002880.html\" target=\"_blank\" class=\"tab-link-news\">Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-17-18 05:50PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-gains-market-225010045.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Gains As Market Dips: What You Should Know</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-07-18 05:45PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-stock-moves-224510436.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Stock Moves -0.54%: What You Should Know</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Dec-04-18 12:51PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-stock-outpacing-175105919.html\" target=\"_blank\" class=\"tab-link-news\">Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-loss\">-5.43%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-30-18 05:41AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/uptrend-continue-aeterna-zentaris-aezs-104110540.html\" target=\"_blank\" class=\"tab-link-news\">Can The Uptrend Continue for Aeterna Zentaris (AEZS)?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Zacks</span> <span class=\"body-table-news-gain\">+7.64%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-19-18 09:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/4-healthcare-stocks-taking-approach-140000983.html\" target=\"_blank\" class=\"tab-link-news\">4 Healthcare Stocks Taking a New Approach to Growth Trends</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> ACCESSWIRE</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-aezs-receives-positive-130000420.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-16-18 10:50AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/4-healthcare-stocks-turning-toward-155000805.html\" target=\"_blank\" class=\"tab-link-news\">4 Healthcare Stocks Turning Toward Tech For New Growth</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> ACCESSWIRE</span> <span class=\"body-table-news-gain\">+14.17%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">07:40AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/consolidated-research-2018-summary-expectations-124000004.html\" target=\"_blank\" class=\"tab-link-news\">Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United  Fundamental Analysis, Key Performance Indications</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-06-18 07:54PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-3q-earnings-snapshot-005411760.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris: 3Q Earnings Snapshot</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Associated Press</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">06:14PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-reports-third-quarter-231402843.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-settles-dispute-cogas-130000690.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Nov-01-18 08:20AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-soars-macrilen-tm-122000958.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Soars on Macrilen(TM) Out Licensing Deal, Analysts Review and Target</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> ACCESSWIRE</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announces-novo-nordisk-120000474.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen in United States and Canada</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">07:50AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/today-research-reports-stocks-watch-115000552.html\" target=\"_blank\" class=\"tab-link-news\">Todays Research Reports on Stocks to Watch: Aeterna Zentaris and AbbVie</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> ACCESSWIRE</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Oct-31-18 04:05PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-announce-third-quarter-200500578.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span> <span class=\"body-table-news-gain\">+67.69%</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\">12:00PM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/3-healthcare-stocks-leading-industry-160000161.html\" target=\"_blank\" class=\"tab-link-news\">3 Healthcare Stocks Leading New Industry Trends</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> ACCESSWIRE</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Sep-25-18 08:00AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/aeterna-zentaris-appoints-leslie-auld-120000844.html\" target=\"_blank\" class=\"tab-link-news\">Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> GlobeNewswire</span></div></div></td></tr>\n<tr><td width=\"130\" align=\"right\" style=\"white-space:nowrap\">Aug-10-18 07:27AM&nbsp;&nbsp;</td><td align=\"left\"><div class=\"news-link-container\"><div class=\"news-link-left\"><a href=\"https://finance.yahoo.com/news/behind-aeterna-zentaris-inc-tse-112736314.html\" target=\"_blank\" class=\"tab-link-news\">What is Behind Aeterna Zentaris Incs (TSE:AEZS) Superior ROE?</a></div><div class=\"news-link-right\"><span style=\"color:#aa6dc0;font-size:9px\"> Simply Wall St.</span></div></div></td></tr>\n</table>\n</td><td width=\"300\" valign=\"top\" style=\"padding-left: 10px\"><div id=\"stocktwits-widget-news\" class=\"fullview-news-outer\"></div>\r\n                                  <script type=\"text/javascript\" defer src=\"//stocktwits.com/addon/widget/2/widget-loader.min.js\"></script>\r\n                                  <script type=\"text/javascript\">\r\n                                    var StocktwitsHeight = document.getElementById('news-table').clientHeight - (FinvizSettings.hasUserPremium ? 0 : 270);\r\n                                    if (StocktwitsHeight > 700 && !FinvizSettings.hasUserPremium) {\r\n                                        StocktwitsHeight -= 270;\r\n                                        var adDiv = document.createElement('div');\r\n                                        adDiv.id = 'IC_D_300x250_2';\r\n                                        adDiv.style.marginTop = '20px';\r\n                                        var stocktwitsContainer = document.getElementById('stocktwits-widget-news');\r\n                                        stocktwitsContainer.parentNode.insertBefore(adDiv, stocktwitsContainer.nextSibling);\r\n                                    }\r\n\r\n                                    function StocktwitsInit() {\r\n                                        if(typeof STWT !== 'undefined') {\r\n                                            var quoteTicker = 'AEZS';\r\n                                            STWT.Widget({\r\n                                                container: 'stocktwits-widget-news',\r\n                                                symbol: quoteTicker,\r\n                                                width: '300',\r\n                                                height: StocktwitsHeight,\r\n                                                limit: '15',\r\n                                                scrollbars: 0,\r\n                                                header: 0,\r\n                                                streaming: 'true',\r\n                                                style: { link_color: '4871a8', link_hover_color: '4871a8', header_text_color: '000000', border_color: 'transparent', border_color_2: 'transparent', divider_color: 'd3d3d3', divider_type: 'solid', box_color: 'transparent', stream_color: 'transparent', text_color: '000000', time_color: '999999', font: 'Verdana, Arial, Tahoma', font_size: 11, time_font_size: 10, username_font: 'Verdana, Arial, Tahoma', username_size: 11 }\r\n                                            });\r\n                                        }\r\n                                    }\r\n                                  </script></td></tr></table></td>\n</tr>\n<tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr class=\"table-light3-row\">\n<td class=\"fullview-profile\" align=\"left\">Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.</td></tr>\n<tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr><td width=\"100%\"><div id=\"statements\"></div></td></tr><tr><td><img src=\"gfx/nic2x2.gif\" width=\"685\" height=\"10\"></td></tr>\n<tr><td width=\"100%\"><img src=\"gfx/nic2x2.gif\" width=\"2\" height=\"10\" alt=\"\" border=\"0\"></td></tr>\n<tr valign=\"bottom\"><td align=\"center\">\n<table  cellpadding=\"0\" cellspacing=\"0\" border=\"0\">\n<tr>\n<td class=\"fullview-links\" align=\"left\" valign=\"center\">\n<a target=\"_blank\" class=\"tab-link\" href=\"https://finance.yahoo.com/quote/AEZS\">open in yahoo</a> | <a target=\"_blank\" class=\"tab-link\" href=\"https://www.reuters.com/companies/AEZS.OQ\">open in reuters</a> | <a target=\"_blank\" class=\"tab-link\" href=\"https://google.com/finance?q=NASDAQ:AEZS\">open in google</a></td>\n</tr>\n</table>\n</td>\n</tr>\n<tr><td width=\"100%\"><img src=\"gfx/nic2x2.gif\" width=\"2\" height=\"10\" alt=\"\" border=\"0\"></td></tr>\n</table>\n</td>\n</tr>\n<tr>\n<td><img src=\"/gfx/nic2x2.gif\" width=\"10\" height=\"20\" alt=\"\" border=\"0\"></td>\n</tr>\n<tr>\n<td align=\"center\"><span class=\"menu-down\"><a class=\"tab-link\" href=\"/affiliate.ashx\">affiliate</a> | <a class=\"tab-link\" href=\"/advertise.ashx\">advertise</a> | <a class=\"tab-link\" href=\"/contact.ashx\">contact</a> | <a class=\"tab-link\" href=\"/privacy.ashx\">privacy</a> | <a class=\"tab-link\" href=\"/help/screener.ashx\">help</a><br><a class=\"tab-link\" href=\"/do_not_sell.ashx\">Do not sell my personal information</a></span>\n<br>\n<span class=\"copyright\">Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.<br>Copyright Â© 2007-2020 FINVIZ.com. All Rights Reserved.</span><br><br></td>\n</tr>\n</table>\n<script type=\"text/javascript\">SearchFocus();</script>\r\n            <script type=\"text/javascript\" src=\"/js/libs/d3.js\"></script>\r\n            <script type=\"text/javascript\" src=\"/js/dist/quote.bundle.js?rev=249\"></script>\r\n        \r\n            <script async src=\"https://www.googletagmanager.com/gtag/js?id=UA-3261808-1\"></script>\r\n            <script>\r\n              window.dataLayer = window.dataLayer || [];\r\n              function gtag(){dataLayer.push(arguments);}\r\n              gtag('js', new Date());\r\n\r\n              gtag('set', {'dimension1': 'NotLoggedIn'});\r\n              gtag('set', {'dimension3': window.devicePixelRatio || 'unknown'});\r\n              \r\n\r\n              gtag('config', 'UA-3261808-1', { sample_rate: 10, send_page_view: false });\r\n              \r\n\r\n              gtag('event', 'page_view', { page_location: location.href, page_path: location.pathname, page_title: document.title });\r\n            </script>\r\n        <script type=\"text/javascript\">\n_qoptions={qacct:\"p-c2W8esUZ6Q8oA\"};\n</script>\n<script type=\"text/javascript\" src=\"https://secure.quantserve.com/quant.js\"></script>\n<noscript>\n<img src=\"https://pixel.quantserve.com/pixel/p-c2W8esUZ6Q8oA.gif\" style=\"display: none;\" border=\"0\" height=\"1\" width=\"1\" alt=\"Quantcast\"/>\n</noscript>\n<div id=\"modal-elite-ad\" class=\"modal-elite-ad\">\r\n                            <div id=\"modal-elite-ad_content\" class=\"modal-elite-ad_content\">\r\n\t\t\t                    <button id=\"modal-elite-ad-close\" type=\"button\" class=\"modal-elite-ad_close\">Ã—</button>\r\n                                \r\n                                <!--<div id=\"modal-elite-ad-content-0\" style=\"display: none\">\r\n\t\t\t                        <h2>Ever heard of Finviz*Elite?</h2>\r\n                                    <p>\r\n                                        Our premium service offers you real-time quotes, advanced visualizations, technical studies, and much more.<br>\r\n                                        Become Elite and make informed financial decisions.\r\n                                    </p>\r\n                                    <a href=\"/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=modal-0\" id=\"modal-elite-ad-btn-0\" class=\"\" target=\"_blank\">Find out more</a>\r\n                                </div>-->\r\n\r\n                                <div id=\"modal-elite-ad-content-1\" style=\"display: block\">\r\n\t\t\t                        <h2>Upgrade your FINVIZ experience</h2>\r\n                                    <p>\r\n                                        Join thousands of traders who make more informed decisions with&nbsp;our&nbsp;premium features.\r\n                                        Real-time quotes, advanced&nbsp;visualizations, backtesting, and much more.\r\n                                    </p>\r\n                                    <a href=\"/elite.ashx?utm_source=finviz&utm_medium=banner&utm_campaign=modal-1\" id=\"modal-elite-ad-btn-1\" class=\"modal-elite_button\" target=\"_blank\">Learn more about FINVIZ*Elite</a>\r\n                                </div>\r\n                            </div>\r\n                         </div><script src=\"/js/pv.js?rev=249\" async></script><script src=\"/script/libs/bowser.min.js?rev=249\" type=\"text/javascript\"></script></body>\n</html>\n"
    headers:
      Cache-Control:
      - no-cache
      Cf-Cache-Status:
      - DYNAMIC
      Cf-Ray:
      - 5f7560877c8d03d4-ORD
      Cf-Request-Id:
      - 069d3aa8a6000003d4d2996000000001
      Content-Type:
      - text/html; charset=utf-8
      Date:
      - Tue, 24 Nov 2020 19:01:10 GMT
      Expect-Ct:
      - max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
      Expires:
      - "-1"
      Pragma:
      - no-cache
      Server:
      - cloudflare
      Set-Cookie:
      - __cfduid=d71794697d50cdbea70664968b7f8b3b41606244470; expires=Thu, 24-Dec-20 19:01:10 GMT; path=/; domain=.finviz.com; HttpOnly; SameSite=Lax; Secure
      - preventRedirectLoop=false; domain=.finviz.com; expires=Mon, 23-Nov-2020 19:01:10 GMT; path=/
      Vary:
      - Accept-Encoding
      X-Aspnet-Version:
      - 4.0.30319
      X-Frame-Options:
      - SAMEORIGIN
      X-Powered-By:
      - ASP.NET
    status: 200 OK
    code: 200
    duration: ""
